Saba Capital Management’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,890
Closed -$10M 932
2022
Q3
$10M Hold
3,890
0.11% 340
2022
Q2
$9.88M Hold
3,890
0.12% 327
2022
Q1
$9.84M Hold
3,890
0.14% 243
2021
Q4
$9.76M Hold
3,890
0.15% 191
2021
Q3
$9.77M Buy
3,890
+825
+27% +$2.04M 0.24% 98
2021
Q2
$7.59M Buy
3,065
+604
+25% +$1.49M 0.22% 104
2021
Q1
$6.04M Buy
+2,461
New +$6.03M 0.19% 100

Other funds holding ICU

Saba Capital Management's ICU Position: Q4 2022 in Review

Saba Capital Management sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 3,890 shares — an estimated $10M sold.

Saba Capital Management first reported a position in ICU in Q1 2021 and held it in 7 quarters. The position peaked at $10M in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

  • Saba Capital Management reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
  • Saba Capital Management sold 3,890 SeaStar Medical shares in Q4 2022, an estimated $10M.
  • Saba Capital Management first reported a position in SeaStar Medical in Q1 2021 and held it in 7 quarters.
  • Saba Capital Management's SeaStar Medical position peaked at $10M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.